RE:RE:RE:General comments, leading to Monday am N.R. Etc Fox,
The audience for this talk was the Cannacord investors, who are not who we really need anyway.
Monday is a more formal talk. But I am not holding out much hope.
Again, sell the freaking company already!
Uncartainties (like competitors being successful) can get you and hurt you in this world.
As an aside, I have only been confident in the company over the last two years because of our stellar clinical results and the development of a scientific understanding of the MOA
. The results, combined with the intelligence we get from Noteable on the market for these assets and the context of BP needing assets, suggests we must be getting a lot of interest and offers. They must be holding out for top dollar, Immunomedics level. That is a big gamble with our assets.